{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:30:46Z","timestamp":1789767046961,"version":"4.0.1"},"reference-count":32,"publisher":"Biomedical Research Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2220\/biomedres.37.153","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T22:06:08Z","timestamp":1461362768000},"page":"153-159","source":"Crossref","is-referenced-by-count":44,"title":["&lt;b&gt;Combination of aspartic acid and glutamic acid inhibits tumor cell proliferatio&lt;\/b&gt;&lt;b&gt;n &lt;\/b&gt;"],"prefix":"10.2220","volume":"37","author":[{"given":"Yoshie","family":"YAMAGUCHI","sequence":"first","affiliation":[{"name":"Department of Placenta avenir research institute, Japan Bio Products Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"YAMAMOTO","sequence":"additional","affiliation":[{"name":"Department of Placenta avenir research institute, Japan Bio Products Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"SATO","sequence":"additional","affiliation":[{"name":"Department of Placenta avenir research institute, Japan Bio Products Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjiro","family":"INOUE","sequence":"additional","affiliation":[{"name":"Department of Placenta avenir research institute, Japan Bio Products Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"MORINAGA","sequence":"additional","affiliation":[{"name":"Department of Placenta avenir research institute, Japan Bio Products Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"HIRANO","sequence":"additional","affiliation":[{"name":"Department of Placenta avenir research institute, Japan Bio Products Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Abdul M and Hoosein N (2005) N-methyl-D-aspartate receptor in human prostate cancer. <i>J Membr Biol<\/i> <b>205<\/b>, 125\u2013128.","DOI":"10.1007\/s00232-005-0777-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Benson AB III, Mitchell E, Abramson N, Klencke B, Ritch P, Burnhan JP, McGuirt C, Bonny T, Levin J and Hohneker J (2002) Oral eniluracil\/5-fluorouracil in patients with inoperable hepatocellular carcinoma. <i>Ann Oncol<\/i> <b>13<\/b>, 576\u2013581.","DOI":"10.1093\/annonc\/mdf079"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Bhaskar PT and Hay N (2007) The two TORCs and Akt. <i>Dev Cell<\/i> <b>12<\/b>, 487\u2013502.","DOI":"10.1016\/j.devcel.2007.03.020"},{"key":"4","unstructured":"4 Cao W, Xu X, Zhang J and Duan Y (2013) Tumor angiogenesis after heated lipiodol infusion via the hepatic artery in a rabbit model of VX2 liver cancer. <i>PLoS One<\/i> <b>24<\/b>, e61583."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Capussotti L, Muratore A, Amisano M, Polastri R, Bouzari H and Massucco P (2005) Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival\u2014a European single center experience. <i>Eur J Sur<\/i><i>g <\/i><i>Oncol<\/i> <b>31<\/b>, 986\u2013993.","DOI":"10.1016\/j.ejso.2005.04.002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, Chen LZ, Tan HX, Li W, Bi J and Zhang LJ (2009) Involvement of PI3K\/PTEN\/AKT\/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. <i>Hepatol Res<\/i> <b>39<\/b>, 177\u2013186.","DOI":"10.1111\/j.1872-034X.2008.00449.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Chen PE, Geballe MT, Stansfeld PJ, Johnston AR, Yuan H, Jacob AL, Snyder JP, Traynelis SF and Wyllie DJ (2005) Structural features of the glutamate binding site in recombinant NR1\/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling. <i>Mol Pharmacol<\/i> <b>67<\/b>, 1470\u20131484.","DOI":"10.1124\/mol.104.008185"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Choi SW, Park SY, Hong SP, Pai H, Choi JY and Kim SG (2004) The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamous cell carcinoma. <i>J Oral Pathol Med<\/i> <b>33<\/b>, 533\u2013537.","DOI":"10.1111\/j.1600-0714.2004.00226.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 O\u2019Keefe EJ and Chiu ML (1998) Stimulation of thymidine incorporation in keratinocytes by insulin, epidermal growth factor, and placental extract: comparison with cell number to assess growth. <i>J Invest Dermatol<\/i> <b>90<\/b>, 2\u20137.","DOI":"10.1111\/1523-1747.ep12462409"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 El-Serag HB (2011) Hepatocellular carcinoma. <i>N Engl J Med<\/i> <b>365<\/b>, 1118\u20131127.","DOI":"10.1056\/NEJMra1001683"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. <i>Nat Rev Cancer<\/i> <b>9<\/b>, 550\u2013562.","DOI":"10.1038\/nrc2664"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and Gonzalez-Baron M (2004) PI3K\/Akt signalling pathway and cancer. <i>Cancer Treat Rev<\/i> <b>30<\/b>, 193\u2013204.","DOI":"10.1016\/j.ctrv.2003.07.007"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Gills JJ and Dennis PA (2009) Perifosine: update on a novel Akt inhibitor. <i>Curr Oncol Rep<\/i> <b>11<\/b>, 102\u2013110.","DOI":"10.1007\/s11912-009-0016-4"},{"key":"14","unstructured":"14 Gish RG, Finn RS and Marrero JA (2013) Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma. <i>Gastroenterol Hepatol (N Y)<\/i> <b>9<\/b>, 1\u201324."},{"key":"15","unstructured":"15 Iwai K, Maeda H and Konno T (1984) Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. <i>Cancer Res<\/i> <b>44<\/b>, 2115\u20132121."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Johnson PJ (2002) Hepatocellular carcinoma: Is current therapy really altering outcome? <i>Gut<\/i> <b>51<\/b>, 459\u2013462.","DOI":"10.1136\/gut.51.4.459"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Lang H, Sotiropoulos GC, Brokalaki EI, Schmitz KJ, Bertona C, Meyer G, Frilling A, Paul A, Malago M and Broelsch CE (2007) Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. <i>J Am Coll Surg<\/i> <b>205<\/b>, 27\u201336.","DOI":"10.1016\/j.jamcollsurg.2007.03.002"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Liu JW, Kim MS, Nagpal J, Yamashita K, Poeta L, Chang X, Lee J, Park HL, Jeronimo C, Westra WH, Mori M, Moon C, Trink B and Sidransky D (2007) Quantitative hypermethylation of NMDAR2B in human gastric cancer. <i>Int J Cancer<\/i> <b>121<\/b>, 1994\u20132000.","DOI":"10.1002\/ijc.22934"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Liu K, Kato Y, Kaku T and Sugiyama Y (1998) Human placental extract stimulates liver regeneration in rats. <i>Biol Pharm Bull<\/i> <b>21<\/b>, 44\u201349.","DOI":"10.1248\/bpb.21.44"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Llovet JM, Ruff P, Tassopoulos N, Castells L, Bruix J, El-Hariry I and Peachey M (2001) A phase II trial of oral eniluracil\/5-fluorouracil in patients with inoperable hepatocellular carcinoma. <i>Eur J Cancer<\/i> <b>37<\/b>, 1352\u20131358.","DOI":"10.1016\/S0959-8049(01)00100-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. <i>J Nutr<\/i> <b>130 (4S Suppl)<\/b>, 1007S\u20131015S.","DOI":"10.1093\/jn\/130.4.1007S"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 <b>Suppl)<\/b>, 1007S\u20131015S. Murata K and Moriyama M (2007) Isoleucine, an essential amino acid, prevents liver metastases of colon cancer by antiangiogenesis. <i>Cancer Res<\/i> <b>67<\/b>, 3263\u20133268.","DOI":"10.1158\/0008-5472.CAN-06-3739"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Morimoto K, Sakaguchi H, Tanaka T, Yamamoto K, Anai H, Hayashi T, Satake M and Kichikawa K (2008) Transarterial chemoembolization using cisplatin powder in a rabbit model of liver cancer. <i>Cardiovasc Intervent Radiol<\/i> <b>31<\/b>, 981\u2013985.","DOI":"10.1007\/s00270-008-9367-8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 N\u2019Kontchou G, Mahamoudi A, Aout M, Ganne-Carri\u00e9 N, Grando V, Coderc E, Vicaut E, Trinchet JC, Sellier N, Beaugrand M and Seror O (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. <i>Hepatology<\/i> <b>50<\/b>, 1475\u20131483.","DOI":"10.1002\/hep.23181"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Reeds PJ and Biolo G (2002) Non-protein roles of amino acids: an emerging aspect of nutrient requirements. <i>Curr Opin Clin Nutr Metab Care<\/i> <b>5<\/b>, 43\u201345.","DOI":"10.1097\/00075197-200201000-00008"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Sugiyama K, Yu L and Nagasue N (1998) Direct effect of branched-chain amino acids on the growth and metabolism of cultured human hepatocellular carcinoma cells. <i>Nutr Cancer<\/i> <b>31<\/b>, 62\u201368.","DOI":"10.1080\/01635589809514679"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Togashi S, Takahashi N, Iwama M, Watanabe S, Tamagawa K and Fukui T (2002) Antioxidative collagen-derived peptides in human-placenta extract. <i>Placenta<\/i> <b>23<\/b>, 497\u2013502.","DOI":"10.1053\/plac.2002.0833"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Toker A and Yoeli-Lerner M (2006) Akt signaling and cancer: surviving but not moving on. <i>Cancer Res<\/i> <b>66<\/b>, 3963\u20133966.","DOI":"10.1158\/0008-5472.CAN-06-0743"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Watanabe S, Kimura Y, Shindo K and Fukui T (2006) Effect of human placenta extract on potassium oxonate-induced elevation of blood uric acid concentration. <i>J Health Sci<\/i> <b>52<\/b>, 738\u2013742.","DOI":"10.1248\/jhs.52.738"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Yamaguchi F, Hirata Y, Akram H, Kamitori K, Dong Y, Sui L and Tokuda M (2013) FOXO\/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801. <i>BMC Cancer<\/i> <b>13<\/b>, 468\u201378.","DOI":"10.1186\/1471-2407-13-468"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Zhong C, Guo RP, Li JQ, Shi M, Wei W, Chen MS and Zhang YQ (2009) A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for stage III A hepatocellular carcinoma. <i>J Cancer Res Clin Oncol<\/i> <b>135<\/b>, 1437\u20131445.","DOI":"10.1007\/s00432-009-0588-2"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Zhong JH, Li H, Li LQ, You XM, Zhang Y, Zhao YN, Liu JY, Xiang BD and Wu GB (2012) Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials. <i>Eur J Surg Oncol<\/i> <b>38<\/b>, 286\u2013295.","DOI":"10.1016\/j.ejso.2012.01.006"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/37\/2\/37_153\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T23:51:33Z","timestamp":1567813893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/37\/2\/37_153\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.37.153","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}